Cambodia vs North America: Tuberculosis treatment success rate
Tuberculosis treatment success rate over time
- Cambodia
- North America
How they compare
Cambodia currently reports 96.0% against 79.0% in North America, a difference of 17.0%.
That makes Cambodia's figure about 1.2 times North America's.
Across all 24 years both countries report, Cambodia has been ahead every year.
Cambodia ranks 15th and North America ranks 15th of 203 countries.
Cambodia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cambodia | North America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.3% | 79.5% | 12.8% | Cambodia |
| 2010s | 93.5% | 78.8% | 14.7% | Cambodia |
| 2020s | 95.8% | 75.5% | 20.2% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Cambodia or North America?
- Cambodia, at 96.0% against 79.0% in North America as of 2023.
- What is the difference in tuberculosis treatment success rate between Cambodia and North America?
- 17.0%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and North America?
- 24 years are reported by both, from 2000 to 2023.
- How do Cambodia and North America rank globally for tuberculosis treatment success rate?
- Cambodia ranks 15th and North America ranks 15th of 203 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Tuberculosis treatment success rate (% of new cases). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Tuberculosis treatment success rate is the percentage of all new tuberculosis cases (or new and relapse cases for some countries) registered under a national tuberculosis control programme in a given year that successfully completed treatment, with or without bacteriological evidence of success ("cured" and "treatment completed" respectively).